Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine for Acute Rehabilitation After Radical Cystectomy
NCT03047057Phase 2Completed
- Sponsor
- Assiut University
- Start
- Mar 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative ileus (POI), sponsored by Assiut University. Primary endpoint: Postoperative return of gastrointestinal function at 15 days. Started Mar 2017; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on NCT03047057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03047057.